A Material Difference 

Regenity Biosciences advances new frontiers in regenerative science, turning bioabsorbable materials into life-changing solutions. Sought after for our novel resorbable technologies and distinct approach to contract manufacturing and contract development, our team brings the urgency and vision to deliver breakthrough medtech solutions for medical technology and medical device manufacturers of all sizes.

View Products & Solutions

Collagen Matrix is now
Regenity Biosciences.

As part of our vision to be the global leader in bioresorbable technologies for tissue and bone repair, we’ve rebranded as Regenity Biosciences. We’re also excited to share that we’ve acquired Polyganics. This has expanded our portfolio with versatile bioresorbable and biocompatible synthetic polymers to repair natural tissue across ENT, neurosurgery, and general surgery applications.

Mission & Values

Every day, we work to make a material difference in the lives of patients. With people’s health on the line, it’s our duty to act with urgency and diligence. It is this collective ethos that drives us each day to push the boundaries of what’s possible in tissue repair and regeneration.

Discover the Difference

Urgency

Patients depend on us delivering our products with enthusiasm, efficiency, and diligence. Our obligation and privilege is to drive urgency on patients’ behalf.

Creativity

We are passionate trailblazers, relentless in our pursuit of continuous improvement.

Determination

We are passionate, dedicated, and tenacious about our goals.

Integrity

We act in all ways with respect and transparency, ethically and honestly, with everyone. Our work represents who we are, as we create products we can proudly recommend to our loved ones.

Collaboration

We are only successful together, operating as one diverse and inclusive team with each other and our customers.

About Regenity

There’s an art and a science to regenerative science. Our scientists and inventors transform tissue healing, from product concept through commercialization. As subject matter experts in material production and processing, product development, and manufacturing, we design and produce advanced devices and implants that support the body’s natural ability to regenerate.  

Learn More

Products & Services

For more than 25 years, Regenity has supported clients around the world looking to accelerate time-to-market, augment their product portfolio, create new innovations, manufacture new products, and gain regulatory approval. We offer a vast array of raw materials, contract manufacturing, and contract development solutions for medical technology clients.

Learn More

Technology Platforms

Applying our state-of-the-art proprietary technology platforms, we develop bioresorbable and biocompatible materials for use in a range of medical and dental applications, driving tissue regeneration and functional patient recovery.

Learn More

86

Medical device approvals in 86 countries

View Our Regulatory Services
View Our Regulatory Services

4m+

Devices a year delivered to medical technology clients

25m

Devices produced since inception

Highlights

Read about our latest news, and download available product brochures.

View All

Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care

PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…

Learn More

Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study

Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…

Learn More

Natsuyo Lee Reflects on 20 Years at Regenity

Natsuyo Lee (Nat) plays a pivotal role in bringing innovation to life at Regenity Biosciences….

Learn More

Dan Fernandez Returns to Regenity

Meet Daniel Fernandez, our Regulatory Specialist, whose journey is a testament to the incredible…

Learn More

Congratulations Peggy Hansen

We’re thrilled to announce that our very own Peggy Hansen, General Manager, Contract…

Learn More

Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences

The rebrand supports the company’s position as material transformers in regenerative implant…

Learn More

Vice President of R&D, Dan Ammon, inaugurated into the National Academy of Engineering (NAE)

We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…

Learn More

Collagen Matrix Names Tim Starr Chief Operating Officer

We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen…

Learn More

Collagen Matrix Acquires Polyganics

The Investment Expands CMI’s Regenerative Medicine Portfolio, R&D Capabilities and…

Learn More

Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market

OAKLAND, NJ — 6/28/22 — Collagen Matrix, Inc., a leader in regenerative medicine, global…

Learn More

Careers

Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.

See Open Positions

Let’s Connect

Looking for a reliable partner to fill your product portfolio gap, co-create your next great innovation or manufacture your products?
Let’s Connect